inflamm
essenti
host
defenc
infect
damag
excess
resolut
inflamm
activ
process
proresolut
effect
lipoxin
resolvin
protectin
receiv
signific
interest
review
emerg
data
role
lipid
mediat
infecti
diseas
lipoxin
influenc
host
control
mycobacterium
tuberculosi
toxoplasma
gondii
trypanosoma
cruzi
plasmodium
berghei
cerebr
malaria
mice
effect
protect
toxoplasmosi
cruzi
infect
cerebr
malaria
detriment
tuberculosi
relat
balanc
pathogencontrol
excess
immun
respons
topic
lipoxin
abrog
tissu
damag
seen
rabbit
model
porphyromona
gingivali
periodont
increas
virul
influenza
viru
mice
correl
reduc
express
requir
mediat
effect
lipoxin
mice
unabl
synthes
lipoxin
suffer
increas
lung
patholog
respiratori
syncyti
viru
infect
protectin
suppress
influenza
viru
replic
vitro
increas
surviv
mous
model
sever
influenza
infect
resolvin
investig
number
anim
model
system
bacteri
infect
found
enhanc
phagocyt
clearanc
bacteria
reduc
inflamm
sever
promot
neutrophil
apoptosi
modul
neutrophil
chemotaxi
importantli
reduc
mortal
interestingli
resolvin
also
enhanc
antibacteri
effect
ciprofloxacin
vancomycin
topic
resolvin
applic
reduc
sever
herp
simplex
viru
ocular
infect
mice
effect
mediat
translat
preclin
studi
success
clinic
trial
repres
promis
new
strategi
manag
infecti
diseas
inflamm
essenti
host
defenc
mechan
requir
protect
pathogen
microorgan
virus
howev
excess
nonresolv
inflammatori
respons
damag
host
exampl
sepsi
loss
homeostat
control
inflammatori
respons
mount
infecti
agent
result
proinflammatori
procoagul
state
result
organ
dysfunct
death
acut
respiratori
distress
syndrom
anoth
exampl
describ
lifethreaten
hypox
complic
excess
pulmonari
inflamm
trigger
rang
insult
includ
pneumonia
sepsi
chronic
nonresolv
inflamm
also
underpin
number
pulmonari
diseas
includ
asthma
cystic
fibrosi
bronchiectasi
inflamma
critic
event
follow
clearanc
infecti
agent
prevent
develop
complic
excess
inflamm
known
activ
process
term
catabasi
driven
proresolut
lipid
mediat
resolvin
protectin
lipoxin
lipoxin
trihydroxytetraenecontain
eicosanoid
deriv
polyunsatur
fatti
acid
arachidon
acid
sequenti
reaction
involv
lipoxygenas
enzym
includ
type
human
mucos
tissu
resolvin
deriv
polyunsatur
fatti
acid
exist
two
seri
e
dseri
resolvin
product
docosahexaeno
acid
metabol
involv
eseri
resolvin
synthes
eicosapentaeno
acid
involv
aspirinacetyl
cyclooxygenas
protectin
also
polyunsatur
fatti
acid
deriv
gener
docosahexaeno
acid
pathway
proresolut
effect
mediat
exemplifi
role
pulmonari
inflamm
set
best
studi
resolvin
protectin
lipoxin
proresolut
role
mous
model
allerg
airway
inflamm
given
excess
inflammatori
respons
implic
pathogenesi
number
infecti
diseas
complic
includ
sepsi
syndrom
acut
respiratori
distress
syndrom
conduct
review
literatur
determin
current
known
role
proresolut
lipid
mediat
lipoxin
resolvin
protectin
infecti
diseas
mice
virul
infect
result
shorter
surviv
time
strain
dissemin
extrapulmonari
site
brain
spleen
follow
intranas
inocul
global
transcript
respons
infect
analys
show
differ
strain
influenza
viru
caus
differ
earli
respons
gene
express
mani
differenti
regul
gene
compon
inflammatori
respons
infect
associ
upregul
inflammasom
gene
includ
caspas
tumour
necrosi
factora
tnfa
interferonc
ifnc
protein
kinas
r
well
inflammationrel
gene
use
bioinformat
approach
analys
gene
express
author
found
extrapulmonari
dissemin
associ
downregul
gene
involv
mediat
proresolut
effect
lipoxin
leucocyt
recruit
counterregul
proinflammatori
cytokin
induct
includ
suppressor
cytokin
signal
soc
gene
product
activ
lipoxin
essenti
intracellular
mediat
lipoxin
effect
inflammatori
cell
traffick
cytokin
induct
therefor
loss
lipoxin
proresolut
effect
may
associ
greater
influenza
viru
virul
suggest
protect
role
lipoxin
infect
possibl
relat
suppress
proinflammatori
cytokin
upregul
model
highli
pathogen
avian
viru
use
studi
less
success
spread
human
host
compar
influenza
viru
strain
exampl
pandem
strain
success
pathogen
minim
damag
host
prolong
avail
replic
nich
high
casemort
seen
infect
strain
indic
well
adapt
human
reduct
lipoxinmedi
proresolut
effect
may
contribut
viru
poor
adapt
human
recent
studi
respiratori
syncyti
viru
rsv
infect
mice
defici
enzym
requir
lipoxin
product
fail
elicit
altern
macrophag
differenti
known
requir
resolut
rsvinduc
lung
injuri
altern
activ
macrophag
thought
induc
antiinflammatori
cytokin
express
drive
lung
tissu
repair
significantli
rsv
infect
mice
result
greater
lung
patholog
histolog
analysi
increas
peribronchiol
perivascul
interstiti
pneumon
alveol
comparison
infect
wildtyp
mice
treatment
lipoxin
resolvin
partial
restor
altern
activ
macrophag
phenotyp
mice
observ
support
proresolut
role
lipoxin
viral
respiratori
tract
infect
alveolar
macrophag
major
resid
inflammatori
cell
respiratori
tract
abl
produc
lipoxin
alveolar
macrophag
isol
rat
previous
infect
rang
respiratori
virus
murin
parainfluenza
viru
type
rat
coronaviru
pneumonia
viru
mice
mous
adenoviru
produc
higher
level
lipoxin
macrophag
rat
kept
steril
condit
sinc
birth
find
suggest
virusinduc
pulmonari
inflamm
stimulu
product
lipoxin
cell
cultur
model
hiv
central
nervou
system
infect
follow
cocultur
hivinfect
monocyt
astroglia
tnfa
produc
product
correl
synthesi
larg
amount
leukotrien
leukotrien
lipoxin
studi
demonstr
albeit
vitro
lipoxin
produc
direct
respons
viral
infect
howev
role
lipoxin
model
infect
investig
follow
aerosol
infect
mycobacterium
tuberculosi
mice
shown
produc
high
level
lipoxin
chronic
infect
pulmonari
endotheli
cell
macrophag
respons
transgen
mice
defici
enzym
requir
lipoxin
product
abl
control
tuberculosi
infect
better
wildtyp
mice
demonstr
lower
pulmonari
splenic
titr
viabl
tuberculosi
day
histolog
examin
lung
tissu
extens
inflamm
area
necrosi
seen
wildtyp
mice
wherea
transgen
mice
lesser
degre
inflamm
littl
evid
necrosi
importantli
transgen
mice
unabl
produc
lipoxin
enjoy
enhanc
surviv
model
tuberculosi
infect
increas
pulmonari
level
ifnc
induc
nitric
oxid
synthas
known
protect
role
host
control
tuberculosi
infect
mice
oral
administr
lipoxin
analogu
revers
enhanc
control
infect
transgen
mice
splenocyt
mice
show
reduc
ifnc
product
mous
model
toxoplasma
gondii
infect
establish
intraperiton
inocul
gondii
cyst
serum
level
lipoxin
rise
infect
remain
high
chronic
infect
establish
transgen
mice
unabl
produc
lipoxin
suffer
increas
mortal
follow
infect
compar
wildtyp
control
anim
interestingli
fewer
gondii
brain
cyst
seen
lipoxindefici
mice
consist
lower
parasit
burden
increas
serum
level
ifnc
seen
compar
wildtyp
mice
therefor
seem
like
increas
mortal
lipoxindefici
mice
attribut
cytokinemedi
tissu
damag
despit
better
parasit
control
corrobor
increas
histolog
sever
mening
enceph
observ
transgen
mice
administr
lipoxin
analogu
rescu
lipoxindefici
mice
fatal
phenotyp
lower
ifnc
level
wildtyp
level
case
ifnc
produc
antigenpres
cell
dendrit
cell
import
role
host
control
intracellular
pathogen
gondii
virus
excess
caus
immunopatholog
mice
shown
lipoxin
analogu
suppress
product
dendrit
cell
stimul
gondii
extract
although
may
hostdriven
respons
curb
excess
inflamm
induct
lipoxin
product
could
strategi
adopt
pathogen
modul
host
immun
perhap
facilit
chronic
infect
reduc
tissu
damag
contrast
role
lipoxin
two
model
infect
may
relat
dynam
specif
pathogenhost
interact
toxoplasma
gondii
replic
quickli
tuberculosi
risk
excess
inflamm
ensu
immunopatholog
may
therefor
greater
prevent
lipoxin
benefici
host
enhanc
surviv
mycobacterium
tuberculosi
induc
weaker
helper
cell
respons
mice
gondii
replic
slowli
therefor
enhanc
inflammatori
respons
seen
lipoxindefici
mice
may
advantag
toppingup
exist
host
control
reduc
tissu
damag
seen
lipoxindefici
mice
may
result
better
control
tuberculosi
replic
also
import
note
local
lung
versu
peritoneum
brain
biosynthesi
action
lipoxin
may
differ
two
infect
model
could
provid
altern
explan
differ
outcom
observ
mous
model
trypanosoma
cruzi
infect
found
administr
aspirin
acetylsalicyl
acid
dose
mgkg
increas
surviv
decreas
peak
parasitaemia
wherea
higher
lower
dose
effect
aspirintrigg
lipoxin
found
increas
administr
aspirin
vitro
vivo
model
infect
infect
alon
also
increas
level
exogen
administr
found
decreas
parasitaemia
peak
decreas
cardiac
inflamm
increas
surviv
author
therefor
hypothes
benefici
effect
aspirin
infect
mice
result
product
may
repres
new
therapeut
strategi
acut
phase
chaga
diseas
wildtyp
mice
infect
plasmodium
bergheianka
model
cerebr
malaria
wildtyp
mice
enjoy
significantli
increas
surviv
comparison
mice
level
parasitaemia
similar
group
lipoxindefici
mice
increas
cerebr
parasit
burden
day
despit
reduc
cerebr
inflamm
less
ifnc
cell
brain
tissu
lipoxindefici
mice
found
higher
serum
level
ifnc
associ
pathogenesi
murin
cerebr
malaria
significantli
treatment
significantli
prolong
surviv
wildtyp
lipoxindefici
mice
well
reduc
express
ifnc
brain
mortal
rate
differ
significantli
lipoxin
administ
day
infect
day
later
lipoxin
therefor
appear
increas
host
surviv
mous
model
cerebr
malaria
limit
inflamm
enhanc
control
parasit
level
serhan
cowork
use
rabbit
model
periodont
investig
effect
lipoxin
infect
applic
dental
ligatur
plu
porphyromona
gingivali
result
soft
tissu
loss
histolog
leucocyt
infiltr
radiolog
bone
loss
featur
periodont
wildtyp
rabbit
author
use
transgen
rabbit
overexpress
enzym
result
threefold
fourfold
increas
lipoxin
product
transgen
anim
follow
procedur
establish
periodont
none
clinic
histolog
radiograph
featur
found
wildtyp
anim
bone
loss
could
prevent
administr
intraven
metronidazol
confirm
p
gingivali
infect
respons
featur
seen
wildtyp
rabbit
subject
periodont
induct
administ
topic
lipoxin
analogu
protect
anim
gross
soft
tissu
destruct
leucocyt
accumul
bone
loss
periodont
infecti
diseas
though
tissu
damag
characterist
condit
thought
driven
aberr
host
respons
infect
set
experi
serhan
et
al
demonstr
lipoxin
role
curb
excess
respons
protect
effect
vivo
perform
transcript
profil
model
epitheli
cell
expos
lipoxin
canni
et
al
found
lipoxin
upregul
express
bactericidalpermeabilityincreas
protein
bpi
bpi
innat
immun
defenc
molecul
activ
gram
neg
bacteria
bactericid
effect
bacteri
cell
membran
neutral
lipopolysaccharid
opsonin
confirm
four
epitheli
cell
line
pulmonari
epitheli
cell
build
known
bactericid
effect
epitheliumderiv
bpi
gramneg
bacteria
author
sought
examin
effect
lipoxin
epitheli
kill
salmonella
typhimurium
epitheli
cell
cultur
preexpos
lipoxin
analogu
incub
typhimurium
result
concentrationdepend
increas
bacteri
kill
compar
nonpretr
cultur
enhanc
bactericid
activ
could
significantli
inhibit
addit
antibpi
indic
induct
bpi
larg
respons
lipoxinmedi
enhanc
kill
typhimurium
interestingli
mous
model
noninfecti
dextran
sodiumsulphateinduc
coliti
oral
administr
lipoxin
analogu
reduc
weight
loss
passag
blood
per
rectum
mortal
affirm
role
gastrointestin
mucos
inflammatori
condit
caecal
ligat
punctur
mice
establish
microbi
sepsi
consid
similar
pathophysiolog
sepsi
human
model
comparison
control
treatment
intraven
administr
resolvin
reduc
viabl
bacteri
load
blood
periton
exud
absenc
direct
antibacteri
effect
reduc
neutrophil
migrat
periton
caviti
addit
histolog
evid
seen
enhanc
phagocytosi
bacteria
inguin
lymph
node
vitro
incub
resolvin
enhanc
zymosan
phagocytosi
macrophag
obtain
peritoneum
resolvinna
mice
incub
resolvin
human
neutrophil
demonstr
enhanc
phagocytosi
escherichia
coli
also
increas
intracellular
product
reactiv
oxygen
speci
furthermor
plasma
level
proinflammatori
cytokin
tnfa
reduc
resolvin
mice
importantli
effect
proresolut
action
resolvin
increas
surviv
sepsi
mous
model
chiang
et
al
investig
effect
resolvin
use
mous
model
e
coli
periton
involv
intraperiton
inocul
e
coli
found
intraperiton
administr
resolvin
enhanc
phagocytosi
bacteria
comparison
mice
inocul
e
coli
without
resolvin
resolvin
similar
smaller
effect
administr
resolvin
also
associ
significantli
lower
titr
viabl
bacteria
blood
periton
exud
well
lesser
degre
hypothermia
importantli
resolvin
increas
surviv
model
model
microbi
sepsi
discuss
previous
plasma
level
proinflammatori
cytokin
includ
tnfa
reduc
resolvin
administr
interestingli
found
resolvin
enhanc
antimicrobi
effect
ciprofloxacin
resolv
e
coli
periton
given
combin
resolvin
ciprofloxacin
addit
effect
reduc
resolut
interv
time
maximum
concentr
periton
leucocyt
greater
either
agent
given
alon
addit
combin
administr
ciprofloxacin
resolvin
result
lower
titr
viabl
bacteria
blood
periton
exud
enhanc
macrophag
phagocyt
activ
seen
either
agent
alon
effect
reduc
bacteri
titr
still
seen
even
ciprofloxacin
administ
suboptim
concentr
cocktail
resolvin
protectin
staphylococcu
aureu
skin
infect
use
mous
dorsal
skin
pouch
resolvin
plu
protectin
administ
vancomycin
suboptim
concentr
pouch
enhanc
clearanc
bacteria
result
lower
viabl
bacteri
titr
pouch
exud
reduc
neutrophil
infiltr
effect
also
seen
either
resolvin
vancomycin
administ
alon
enhanc
effect
seen
given
togeth
infect
secondari
burn
import
clinic
problem
burnsrel
sepsi
respons
signific
mortal
burn
patient
use
rat
model
burn
injuri
kurihara
et
al
demonstr
neutrophil
isol
burn
rat
impair
abil
migrat
toward
chemoattract
defect
neutrophil
chemotaxi
could
result
inabl
neutrophil
burn
patient
success
reach
kill
infecti
agent
consequ
lost
neutrophil
activ
burn
injuri
may
accumul
initi
tissu
damag
inappropri
healthi
tissu
administ
resolvin
burn
rat
kurihara
et
al
found
neutrophil
chemotaxi
restor
almost
normal
burn
rat
receiv
intraven
lipopolysaccharid
day
burn
injuri
pretreat
intraven
resolvin
improv
surviv
significantli
similarli
resolvin
pretreat
increas
surviv
follow
caecal
ligat
burn
injuri
shorter
durat
resolvin
treatment
insuffici
normal
neutrophil
chemotaxi
significantli
improv
surviv
two
model
burnsrel
sepsi
therefor
studi
suggest
administ
resolvin
could
improv
outcom
burnsrel
sepsi
modul
neutrophil
chemotaxi
role
resolvin
bacteri
pneumonia
acut
lung
injuri
investig
use
mous
model
aspir
pneumonia
mice
administ
hydrochlor
acid
follow
e
coli
lung
resolvin
given
intraven
insult
reduc
pulmonari
neutrophil
infiltr
enhanc
bacteri
clearanc
decreas
level
proinflammatori
cytokin
includ
present
lung
tissu
homogen
importantli
mice
administ
resolvin
enjoy
increas
surviv
day
comparison
salin
administ
neutrophil
apoptosi
known
critic
event
resolut
pulmonari
inflamm
suppress
process
thought
contribut
patholog
seen
acut
respiratori
distress
syndrom
sepsi
casecontrol
cohort
studi
intens
therapi
unit
patient
without
sepsi
level
neutrophil
apoptosi
peripher
venou
blood
found
invers
correl
sever
sepsi
role
resolvin
process
investig
mous
model
acut
lung
injuri
includ
e
coli
pneumonia
model
e
coli
peritonitisassoci
acut
lung
injuri
model
six
hour
intratrach
instil
e
coli
pneumonia
model
intraperiton
administr
resolvin
enhanc
resolut
e
colievok
pneumonia
mous
model
contrast
control
group
mice
administ
resolvin
lower
bronchoalveolar
lavag
neutrophil
count
higher
monocytemacrophag
count
increas
neutrophil
apoptosi
reduc
bronchoalveolar
lavag
level
less
sever
pulmonari
inflamm
assess
histolog
pancaspas
inhibitor
also
ad
intraperiton
proresolut
effect
resolvin
abrog
suggest
neutrophil
apoptosi
play
critic
role
e
coli
peritonitisassoci
acut
lung
injuri
model
intraperiton
administr
resolvin
also
reduc
bronchoalveolar
lavag
neutrophil
count
level
increas
neutrophil
apoptosi
reduc
histolog
sever
pneumonia
well
lung
myeloperoxidas
content
myeloperoxidas
use
marker
neutrophil
activ
importantli
resolvin
administr
reduc
hr
mortal
model
term
possibl
mechan
increas
neutrophil
apoptosi
vitro
resolvin
mitig
cellular
surviv
signal
gener
respons
number
stimuli
relev
pathogenesi
acut
lung
injuri
e
coli
pneumonia
sepsi
neutrophil
myeloperoxidas
serum
amyloid
bacteri
cpg
dna
similarli
also
proapoptot
effect
human
neutrophil
mous
model
e
coli
sepsisinduc
lung
injuri
intraven
lipoxin
reduc
bronchoalveolar
lavag
neutrophil
count
increas
caspasemedi
neutrophil
apoptosi
discuss
although
inflamm
essenti
respons
infect
excess
respons
detriment
stromal
kerat
demonstr
inflammatori
lesion
cornea
sequela
ocular
herp
simplex
viru
infect
usual
appear
week
primari
infect
importantli
stromal
kerat
manifest
replic
viru
detect
therefor
initi
viru
clear
diseas
consequ
nonresolv
excess
inflamm
mice
ocular
herp
simplex
viru
infect
model
stromal
kerat
human
topic
administr
resolvin
abl
control
immunopatholog
manifest
ocular
herp
simplex
viru
reduc
sever
stromal
kerat
lesion
influx
cell
neutrophil
reduc
corneal
level
proinflammatori
cytokin
known
involv
pathogenesi
stromal
kerat
level
antiinflammatori
cytokin
increas
screen
effect
rang
lipid
mediat
replic
influenza
viru
human
lung
epitheli
cell
protectin
found
significantli
reduc
viral
replic
vitro
model
human
sever
influenza
viru
introduc
intratrach
rout
mice
protectin
level
found
reduc
suggest
endogen
product
suppress
viru
influenza
viru
strain
test
reduct
protectin
level
found
invers
correl
virul
viru
strain
use
model
sever
influenza
intraven
administr
protectin
increas
surviv
administr
resolvin
lipoxin
effect
significantli
protect
effect
protectin
still
seen
administ
day
start
infect
lipoxin
resolvin
protectin
endogen
lipid
mediat
proresolut
effect
inflamm
much
work
focus
wellrecogn
role
allerg
airway
inflamm
howev
emerg
theme
import
resolut
infect
associ
inflamm
articl
review
emerg
data
relev
tabl
summar
learnt
anim
studi
role
lipoxin
may
vari
depend
specif
infect
mous
model
tuberculosi
infect
transgen
mice
unabl
produc
lipoxin
abl
control
bacteria
better
reduc
mortal
comparison
wildtyp
express
ifnc
induc
nitric
oxid
synthas
higher
level
contrast
use
transgen
mice
gondii
infect
mortal
higher
despit
lower
parasit
burden
attribut
excess
cytokinemedi
tissu
damag
benefici
effect
also
seen
mous
model
trypanosoma
cruzi
infect
cerebr
malaria
topic
lipoxin
abrog
tissu
bone
damag
seen
rabbit
model
p
gingivali
periodont
therefor
proresolut
effect
lipoxin
may
advantag
protect
host
damag
effect
excess
inflamm
benefit
may
outweigh
situat
permit
uncheck
pathogen
replic
seen
model
tuberculosi
find
administr
lipoxin
enhanc
surviv
mous
model
cerebr
malaria
suggest
potenti
new
therapeut
strategi
human
cerebr
malaria
effect
resolvin
investig
number
mous
model
system
bacteri
infect
found
enhanc
phagocyt
clearanc
bacteria
reduc
neutrophil
influx
inflamm
sever
promot
neutrophil
apoptosi
clearanc
modul
neutrophil
chemotaxi
importantli
reduc
mortal
interestingli
resolvin
administr
also
enhanc
antibacteri
effect
ciprofloxacin
e
coli
periton
vancomycin
staphylococcu
aureu
skin
infect
antimicrobi
administ
suboptim
concentr
topic
resolvin
applic
also
reduc
sever
herp
simplex
viru
ocular
infect
mice
final
protectin
found
increas
surviv
mous
model
sever
influenza
even
administ
day
infect
given
wellrecogn
import
mediat
allerg
airway
inflamm
interest
consid
regul
may
disturb
state
airway
inflamm
induc
infect
exampl
acut
respiratori
distress
syndrom
notabl
pulmonari
product
protectin
found
suppress
highli
pathogen
influenza
strain
evid
cilloniz
et
al
suggest
lipoxinmedi
activ
also
alter
influenza
viru
infect
disturb
lipoxin
regul
could
role
predisposit
toward
asthma
seen
infant
follow
rsv
bronchiol
especi
consid
find
mice
unabl
synthes
lipoxin
fail
elicit
altern
macrophag
differenti
requir
resolut
rsv
diseas
benefici
effect
mediat
translat
preclin
studi
clinic
trial
repres
promis
new
strategi
manag
infecti
diseas
proresolut
antiinflammatori
antimicrobialenhanc
effect
resolvin
protectin
possibl
lipoxin
make
appeal
candid
studi
human
therapeut
perspect
import
note
proresolut
mediat
enjoy
substanti
advantag
steroid
use
treatment
infecti
inflamm
system
inflammatori
state
immunosuppress
agent
aspirintrigg
lipoxin
resolvin
share
proresolut
effect
lipoxin
resolvin
respect
act
intracellular
pathway
effect
uniqu
aspirin
share
nonsteroid
antiinflammatori
drug
trigger
biosynthesi
mediat
due
abil
trigger
product
proresolut
mediat
may
new
role
aspirin
manag
inflammatori
sequela
infecti
diseas
author
declar
compet
interest
